Show me jobs with…
Near this location
For International Job Search Please   Click Here
Company Profile
[ Jobs Posted ]   [ News ]

Headquartered in Paris, Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding $1 billion in 2011.

Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Our development strategy is supported by four franchises: (1) neurology / Dysport®, (2) endocrinology / Somatuline®, (3) uro-oncology / Decapeptyl® and (4) hemophilia. Moreover, the Group has an active policy of partnerships. R&D is focused on innovative and differentiated technological patient driven platforms, peptides and toxins.

In 2011, R&D expenditure totaled more than $300 million, above 21% of Group sales. The Group has total worldwide staff of close to 4,500 employees.

In Milford, Massachusetts, Ipsen Biomeasure Inc is home to 160 Ipsen employees, the Company is currently making a $45 million capital investment in its Milford research and development (R&D) and technical operations facility, notably bioproduction. The facility serves as a center for Ipsen US-based peptide and toxin R&D platforms, as well as a CGMP manufacturing facility focused on production of recombinant proteins for the treatment of hemophilia.

Milford’s renovated facility will house R&D and Process Sciences laboratories that support Ipsen strategic R&D objectives.
[ Go Back ]

Company HR Reps

Susan @ Ipsen


Image not available